Archive

This is my archive

Delos Capital Announces $300 Million First Close of its Third Life Sciences Fund

HONG KONG, Feb. 15, 2022 /PRNewswire/ — Delos Capital, a Hong Kong-headquartered life sciences venture capital fund with a global presence and investment mandate, announces the successful $300 million first close of its Fund III.  The first close of Fund III was completed in only 6 months of fundraising and attracted commitments from reputable investors… Read More